The c-ets1 protooncogene is expressed in human trophoblast during the first trimester of pregnancy

Early Human Development

Volumn 47, Issue 2, 1997, Pages 147-156

  Luton, D ^a,b   Sibony, O ^a   Oury, J F ^a   Blot, P ^a   Dieterlen Lievre F ^b   Pardanaud, L ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b l'alimentation et l'Environnement   (France)

Author keywords

c Ets1, pregnancy; Implantation; Maternofoetal interface; Trophoblast

Indexed keywords

MESSENGER RNA; METALLOPROTEINASE; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ARTICLE; ENDOMETRIUM; FETUS; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; INDUCED ABORTION; PROTO ONCOGENE; TROPHOBLAST;

ANTIGENS, CD34; CHORIONIC VILLI; ENDOMETRIUM; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; PROTO-ONCOGENES; TRANSCRIPTION FACTORS; TROPHOBLASTS;

EID: 0031579257     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-3782(96)01775-6     Document Type: Article

References (36)

1. [1] Macara, L.M., Kingdom, J.C.P. and Kaufmann, P. (1993): Control of the foetoplacental circulation. Fetal Matern. Med. Rev., 5, 167-179.
2. [2] Foidart, J.M., Hustin, J., Dubois, M., Heynen, E. and Schaaps J.P. (1994): La circulation placentaire maternelle s'établit à la 13ème semaine de grossesse. Gynecol. Intern., 7, 217-225.
3. [3] Fox, H. (1983): The pathology of extravillous trophoblast. Arch. Anat. Cytol. Pathol., 31, 73-74.
4. [4] Khong, T.Y., De Wolf, F., Robertson, W.B. and Brosens, I. (1986): Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br. J. Obstet. Gynecol., 93, 1049-1059.
5. [5] Liotta, A., Steeg, P.S. and Stetler-Stevenson, W.G. (1991): Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-336.
6. [6] Leprince, D., Gégonne, A., Coll, J., de Taisne, C., Schneeberger, A., Lagrou, C. and Stéhelin, D. (1983): A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature, 306, 395-397.
7. [7] Nunn, M.F., Seeburg, P.H., Moscovici, C. and Duesberg, P.H. (1983): Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature, 306, 391-395.
8. [8] Seth, A., Ascione, R., Fischer, R.J., Mavrothalassitis, G.J., Bhat, N.K. and Papas, T.S. (1992): The ets gene family. Cell Growth Differ., 3, 327-334.
9. [9] Vandenbunder, B., Pardanaud, L., Jaffredo, T., Mirabel, M.A. and Stéhelin, D. (1989): Complementary patterns of expression of c-ets1, c-myb and c-myc in the blood forming system of the chick embryo. Development, 107, 265-274.
10. [10] Pardanaud, L. and Dieterlen-Lièvre, F. (1993): Expression of c-ets1 in early chick embryo mesoderm: relationship to the hemangioblastic lineage. Cell Adh. Comm., 1, 151-160.
11. [11] Quéva, C., Leprince, D., Stéhelin, D. and Vandenbunder, B. (1993): Differential expression of the two transcription factors encoded by the c-ets1 locus during the development of the chick embryo. Oncogene, 8, 2511-2520.
12. [12] Maroulakou, I.G., Papas, T.S. and Green, J.E. (1994): Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene, 9, 1551-1565.
13. [13] Pardanaud, L., Yassine, F. and Dieterlen-Lièvre, F. (1989): Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development, 105, 473-485.
14. [14] Grevin, D., Chen, J.H., Raes, M.B., Stéhelin, D., Vandenbunder, B. and Desbiens, X. (1993): Involvement of the protooncogene c-ets1 and the urokinase plasminogen activator during mouse implantation and placentation. Int. J. Dev. Biol., 37, 519-529.
15. [15] Wernert, N., Gilles, F., Fafeur, V., Bouali, F., Raes, M.B., Pyke, C., Dupressoir, T., Seitz, G., Vandenbunder, B. and Stéhelin, D. (1994): Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res., 54, 5683-5688.
16. [16] Watson, D.K., McWiffiams, M.J., Lapis, P., Lautenberger, J.A., Schweinfest, C.W. and Papas, T.S. (1988): Mammalian ets-1 and ets-2 genes encode highly conserved proteins. Proc. Natl. Acad. Sci. USA, 85, 7862-7866.
17. [17] Cox, K.H., De Leon, D.V., Angerer, L.M. and Angerer, R.C. (1984): Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev. Biol., 101, 485-502.
18. [18] Silverberg, S.G. and Kurman, R.J. (1991): Gestational trophoblastic disease; Trophoblastic development. In: Tumors of the uterine corpus and gestational trophoblastic disease, pp. 219-231. Editors: Armed Forces Institute of Pathology; Washington DC.
19. [19] Castelluci, M., Scheper, M., Scheffen, I., Celona, A., Kaufmann, P. (1990): The development of the human placental villous tree. Anat. Embryol., 181, 117-128.
20. [20] Wernert, N., Raes, M.B., Lassalle, P., Dehouck, M.P., Gosselin, B., Vandenbunder, B. and Stéhelin, D. (1992): C-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol., 140, 119-127.
21. [21] Vandenbunder B., Quéva, C., Desbiens, X., Wernert, N. and Stéhelin, D. (1994): Expression of the transcription factor c-ets1 correlates with the occurrence of invasive processes during normal and pathological development. Invasion Metastas., 14, 198-209.
22. [22] Boyd, J.O. and Hamilton, W.J. (1970): The human placenta. Heffer and Sons, Cambridge.
23. [23] Holmgren, L., Glaser, A., Pfeifer-Ohlsson, S. and Ohlsson, R. (1991): Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression. Development, 113, 749-754.
24. [24] Charnock-Jones, D.S., Sharkey, A.M., Rajput-Williams, J., Burch, D., Schofield, J.P., Fountain, S.A., Boocock, C.A. and Smith, S.K. (1993): Indentification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod., 48, 1120-1128.
25. [25] Hauser, S. and Weich, H.A. (1993): A heparin-binding form of placenta growth factor (PIGF-2) is expressed in human umbilical vein endothelial cells and placenta. Growth Factors, 9, 259-268.
26. [26] Sharkey, A.M., Charnock-Jones, D.S., Boocok, C.A., Brown, K.D. and Smith, S.K. (1993): Expression of mRNA for vascular endothelial growth factor in human placenta. J. Reprod. Fertil., 99, 609-615.
27. [27] Wheeler, T., Elcock, C.L. and Anthony, F.W. (1995): Angiogenesis and the placental environment. Placenta, 16, 289-296.
28. [28] Multhaupt, H.A.B., Mazar, A., Cines, D.B., Warhol, M.J. and McCrae, K.R. (1994): Expression of urokinase receptors by human trophoblast; A histochemical and ultrastructural analysis. Lab. Invest., 71, 392-400.
29. [29] Harvey, M.B., Leco, K.J., Arcellena-Panlilio, M.Y., Zhang, X., Edwards, D.R. and Schultz, G.A. (1995): Roles of growth factors during pre-implantation development. Mol. Human Reprod., 10, 712-718.
30. [30] Wasylyk, C., Gutman, A., Nicholson, R. and Wasylyk, B. (1991): The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J., 10, 1127-1134.
31. [31] Wasylyk, C. and Wasylyk, B. (1992): Oncogenic conversion alters the transcriptional properties of ets. Cell Growth Differ., 3, 617-625.
32. [32] Nerlov, C., De Cesare, D., Pergola, F., Caracciolo, A., Blasi, F., Johnsen, M. and Verde, P. (1992): A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. EMBO J., 11, 4573-4582.
33. [33] Edwards, D.R., Rocheleau, H., Sharma, R.R., Wills, A.J., Cowie, A., Hassel, J.A. and Heath, J.K. (1992): Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinase-1 (TIMP-1) transcription. Biochem. Biophys. Acta, 1171, 41-55.
34. [34] Bacharach, E., Itin, A., Keshet, E. (1992): In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc. Natl. Acad. Sci. USA, 89, 10686-10690.
35. [35] Sacchi, N., Wendtner, C.M. and Thiele, C.J. (1991): Single-cell detection of ets-1 transcripts in human neuroectodermal cells. Oncogene, 6, 2149-2154.
36. [36] Kola, I., Brookes, S., Green, A.R., Garber, R., Tymms, M., Papas, T.S. and Seth, A. (1993): The ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc. Natl. Acad. Sci. USA, 90, 7588-7592.